JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David J. Pinsky
Henry M. Spotnitz
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soto, P. F.
Right arrow Articles by Spotnitz, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soto, P. F.
Right arrow Articles by Spotnitz, H. M.

J Thorac Cardiovasc Surg 2000;120:39-46
© 2000 The American Association for Thoracic Surgery


CARDIOTHORACIC TRANSPLANTATION

Improvement of rejection-induced diastolic abnormalities in rat cardiac allografts with inducible nitric oxide synthase inhibition

Pablo F. Soto, MDa, Chao-Xiang Jia, MDc, David G. Rabkin, MDc, Joseph P. Hart, MDc, Yvonne M. Carter, MDb, Michael J. Sardo, BSc, Daphne T. Hsu, MDd, Peter E. Fisher, MDf, David J. Pinsky, MDe, Henry M. Spotnitz, MDc

From the Department of Medicine, University of Michigan,a Ann Arbor, Mich; Department of Surgery, University of Washington,b Seattle, Wash; and the Departments of Surgery,c Pediatrics,d Medicine,e and Pathology,f Columbia University College of Physicians & Surgeons, New York, NY.

Supported in part by National Institutes of Health grant HL60900, American Heart Association Grant-in-Aid 92153, National Institutes of Health NRSA grant 1 F32 HL09356-1, and a Columbia University Department of Surgery Startup Funds Grant. Dr Pinsky is an Established Investigator of the American Heart Association.

Address for reprints: Henry M. Spotnitz, MD, Department of Surgery, Columbia College of Physicians & Surgeons, 622 West 168th St, PH 1422, New York, NY 10032 (E-mail: hms2{at}columbia.edu ).

Objective: Inhibition of inducible nitric oxide synthase (nitric oxide II) activity has been proposed as a method to attenuate capillary leak and edema during rejection of heterotopically transplanted rat hearts. Myocardial edema has previously been implicated in diastolic dysfunction during allograft rejection. Accordingly, we tested the hypothesis that inducible nitric oxide synthase inhibition with aminoguanidine would alleviate left ventricular stiffening and myocardial edema formation in 4-day heterotopic rat heart allografts.
Methods: Passive left ventricular filling was studied in American Cancer Institute Lewis rats receiving heterotopic heart transplants receiving either aminoguanidine, a selective nitric oxide synthase inhibitor (n = 6); dexamethasone (1 mg · kg–1 · d–1 administered subcutaneously) for 4 days after transplantation (n = 6); or intravenous saline solution (n = 6). American Cancer Institute–to–American Cancer Institute isografts (n = 6) were used as controls.
Results: Serum nitrite/nitrate levels in the aminoguanidine group (18 ± 3 mmol/L) and dexamethasone group (22 ± 4 mmol/L) were reduced versus the intravenous saline group (144 ± 36 mmol/L [SEM]) to levels seen in controls (25 ± 9 mmol/L). Left ventricular volume at 15 mm Hg for the aminoguanidine group was increased versus that for the intravenous saline solution group, similar to that for controls, and reduced versus dexamethasone-treated animals. Myocardial water content for the aminoguanidine-treated animals (78.3% ± 0.4%) was similar to those of intravenous saline–treated animals (78.0% ± 0.3%) but greater than those of controls (77.1% ± 0.2%) and dexamethasone-treated animals (76.7% ± 0.3%).
Conclusions: Nitric oxide II inhibition with aminoguanidine minimizes the reduction in left ventricular filling that is seen with allograft rejection through a mechanism that is not associated with attenuation of myocardial edema.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. M. Pieper, V. Nilakantan, G. Hilton, X. Zhou, A. K. Khanna, N. L. N. Halligan, C. C. Felix, B. Kampalath, O. W. Griffith, M. A. Hayward, et al.
Variable efficacy of N6-(1-iminoethyl)-L-lysine in acute cardiac transplant rejection
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H525 - H534.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. C. Stoica, D. K. Satchithananda, C. Atkinson, S. Charman, M. Goddard, and S. R. Large
Heat shock protein, inducible nitric oxide synthase and apoptotic markers in the acute phase of human cardiac transplantation
Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 932 - 939.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. M. Pieper, V. Nilakantan, G. Hilton, N. L. N. Halligan, C. C. Felix, B. Kampalath, A. K. Khanna, A. M. Roza, C. P. Johnson, and M. B. Adams
Mechanisms of the protective action of diethyldithiocarbamate-iron complex on acute cardiac allograft rejection
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1542 - H1551.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The American Association for Thoracic Surgery.